Roche extends SMA market lead with Evrysdi tablet approval in Europe

Already offering the only non-invasive treatment for SMA in liquid form, Roche’s Evrysdi now comes as a tablet.

Jun 5, 2025 - 06:00
Roche extends SMA market lead with Evrysdi tablet approval in Europe
Already offering the only non-invasive treatment for SMA in liquid form, Roche’s Evrysdi now comes as a tablet.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow